These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 20214473)

  • 1. The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020.
    Infectious Diseases Society of America
    Clin Infect Dis; 2010 Apr; 50(8):1081-3. PubMed ID: 20214473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial resistance: is there a way out of the woods?
    Marra A
    Future Microbiol; 2011 Jul; 6(7):707-9. PubMed ID: 21797683
    [No Abstract]   [Full Text] [Related]  

  • 3. Questions about the 10 x '20 Initiative.
    Outterson K; Powers JH; Gould IM; Kesselheim AS
    Clin Infect Dis; 2010 Sep; 51(6):751-2; author reply 754-5. PubMed ID: 20731566
    [No Abstract]   [Full Text] [Related]  

  • 4. Coping with antibiotic resistance: the impending crisis.
    Gould IM
    Int J Antimicrob Agents; 2010 Nov; 36 Suppl 3():S1-2. PubMed ID: 21129626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter in response to the Infectious Diseases Society of America's 10 x '20 Initiative.
    Burgess DS; Slain D; Mohr J; Wong-Beringer A; Destache C; Suda K
    Clin Infect Dis; 2010 Sep; 51(6):753; author reply 754-5. PubMed ID: 20731568
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of new antibacterials: a laudable aim, but what is the value?
    Tillotson GS
    Clin Infect Dis; 2010 Sep; 51(6):752-3; author reply 754-5. PubMed ID: 20731567
    [No Abstract]   [Full Text] [Related]  

  • 7. All EU hands to the EU pumps: the Science Academies of Europe (EASAC) recommend strong support of research to tackle antibacterial resistance.
    Gyssens IC
    Clin Microbiol Infect; 2008 Oct; 14(10):889-91. PubMed ID: 18828849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the antibacterial resistance crisis.
    Croft AC; D'Antoni AV; Terzulli SL
    Med Sci Monit; 2007 Jun; 13(6):RA103-18. PubMed ID: 17534243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial drug development: challenges, recent developments, and future considerations.
    Nambiar S; Laessig K; Toerner J; Farley J; Cox E
    Clin Pharmacol Ther; 2014 Aug; 96(2):147-9. PubMed ID: 25056394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing the frustrations of finding new effective antibacterials to combat drug resistant bacteria.
    Fernandes P; Pizza M
    Curr Opin Microbiol; 2008 Oct; 11(5):385-6. PubMed ID: 18804177
    [No Abstract]   [Full Text] [Related]  

  • 11. Currently available antimicrobial agents and their potential for use as monotherapy.
    Peterson LR
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():30-45. PubMed ID: 19040464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Late stage antibacterial drugs in the clinical pipeline.
    Projan SJ; Bradford PA
    Curr Opin Microbiol; 2007 Oct; 10(5):441-6. PubMed ID: 17950658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precompetitive research: a new prescription for drug development?
    Woodcock J
    Clin Pharmacol Ther; 2010 May; 87(5):521-3. PubMed ID: 20407454
    [No Abstract]   [Full Text] [Related]  

  • 14. Global drug discovery: Europe is ahead.
    Light DW
    Health Aff (Millwood); 2009; 28(5):w969-77. PubMed ID: 19706628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antibiotics--resistance is futile.
    Powledge TM
    PLoS Biol; 2004 Feb; 2(2):E53. PubMed ID: 14966545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimicrobial resistance: no action today, no cure tomorrow.
    Sharma A
    Indian J Med Microbiol; 2011; 29(2):91-2. PubMed ID: 21654100
    [No Abstract]   [Full Text] [Related]  

  • 17. Future antibiotics scenarios: is the tide starting to turn?
    Theuretzbacher U
    Int J Antimicrob Agents; 2009 Jul; 34(1):15-20. PubMed ID: 19342202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibiotic pipeline--challenges, costs, and values.
    Wenzel RP
    N Engl J Med; 2004 Aug; 351(6):523-6. PubMed ID: 15295041
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulatory opportunities to encourage technology solutions to antibacterial drug resistance.
    Finch R;
    J Antimicrob Chemother; 2011 Sep; 66(9):1945-7. PubMed ID: 21700629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overcoming the current deadlock in antibiotic research.
    Schäberle TF; Hack IM
    Trends Microbiol; 2014 Apr; 22(4):165-7. PubMed ID: 24698433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.